Skip to main content
. 2022 Feb 21;3:804605. doi: 10.3389/falgy.2022.804605

Table 1.

Summary of proliferation data to beta lactam antibiotics.

Patients ID Symptoms Patient group Culprit drug SI SI SI
CD3, cfse low CD4, cfse low CD8, cfse low
1 515 Anaphylaxis A Amoxicillin 1.0 1.0 0.9
2 506 Anaphylaxis A Amoxicillin 3.7 3.5 1.0
3 700 Anaphylaxis A Cefuroxim 1.3 1.4 0.9
4 699 Anaphylaxis A Cefuroxim 1.2 1.3 2.0
5 31 MPE B Amoxicillin 11.3 9.3 20.7
6 492 MPE B Amoxicillin 10.8 5.2 25.7
7 491 MPE B Amoxicillin 25.8 49.4 14.8
8 466 MPE B Amoxicillin 7.0 8.0 0.0
9 244 MPE B Amoxicillin 10.0 11.0 0.0
10 689 MPE B Amoxicillin 5.2 5.4 4.8
11 687 MPE B Amoxicillin 2.1 2.3 0.5
12 698 DRESS C Amoxicillin 1.0 0.9 1.2
13 694 DRESS C Amoxicillin 8.7 7.9 0.2
14 697 DRESS C Ceftriaxone 3.2 3.5 1.4
15 696 DRESS C Ceftriaxone 18.4 19.8 17.1
16 695 SJS D Amoxicillin 0.9 0.9 0.5
17 404 SJS D Amoxicillin 1.0 1.1 0.9
18 460 SJS D Amoxicillin 0.9 1.0 0.8

SI, stimulation index: ratio of CFSElow population in drug stimulated condition normalized by the control (no drug).